Dr. Peter Hotez, co-director of the Texas Children’s Hospital’s Center for Vaccine Development in Houston har i flere år jobbet med en vaksine som kanskje kunne ha stoppet korona-pandemien, for fire år siden var den klar for testing på mennesker, men de fikk ikke tak i finansiering så prosjektet ble lagt på is. Det passet ikke markedet.
«We tried like heck to see if we could get investors or grants to move this into the clinic,» said Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital and dean of the National School of Tropical Medicine at the Baylor College of Medicine in Houston. «But we just could not generate much interest.»
«That kind of research — figuring out which vaccine strategies work and which don’t — potentially could have been completed before the new outbreak, said Jason Schwartz, a professor at the Yale School of Public Health who studies vaccine development. He said the global response to the coronavirus exposes broader flaws in the way medical research is funded, which he says tends to be market-driven and reactive, rather than proactive.»
–CBS News 05.03.2020